Diagnostic marrow slides, together with one from the first marrow relapse of each patient and one from the second relapse where this was available, were all stained by May Grunwald Giemsa and shuffled and coded to mask the identity of the patients and the stage of disease. All slides were then FAB typed by one observer (JSL), whereupon they were reshuffled and recoded, and the exercise was repeated. When it was discovered that different FAB types had been ascribed to the same slide on the two occasions, the relevant slides were coded yet again and typed 'blind' for a third time, the final FAB type assigned being the best of three. The criteria of the FAB group were adhered to as strictly as possible during the whole exercise, and the significance of the incidence of change in those typed as FAB Li and FAB L2 at diagnosis was assessed using the Chi-squared test.
Proposals for the morphological classification of the acute leukaemias by an international co-operative group in 19761 have been widely adopted, and on this basis lymphoblastic leukaemia (ALL) has been divided into three subgroups, FAB Li, FAB L2, and FAB L3. The criteria for inclusion in these categories are based on cell size, nuclear configuration, prominence of nucleoli, and Romanowsky staining characteristics.
Since Diagnostic marrow slides, together with one from the first marrow relapse of each patient and one from the second relapse where this was available, were all stained by May Grunwald Giemsa and shuffled and coded to mask the identity of the patients and the stage of disease. All slides were then FAB typed by one observer (JSL), whereupon they were reshuffled and recoded, and the exercise was repeated. When it was discovered that different FAB types had been ascribed to the same slide on the two occasions, the relevant slides were coded yet again and typed 'blind' for a third time, the final FAB type assigned being the best of three. The criteria of the FAB group were adhered to as strictly as possible during the whole exercise, and the significance of the incidence of change in those typed as FAB Li and FAB L2 at diagnosis was assessed using the Chi-squared test.
Results
During the study period 33 patients with ALL sustained at least one unequivocal bone marrow relapse and had adequate diagnostic and first relapse material for examination. Slides Only five (21 %) of the FAB Li group retained their morphology at the onset of their ultimate relapse, of whom three had T-cell markers. This small group showed no better prognosis than the remainder, despite similar treatment.
Discussion
These results clearly indicate that blast cell morphology frequently changes during the evolution of refractory ALL. They also show that such change is consistent from a smaller more lymphoid cell to a larger less well differentiated one, and it therefore appears that the FAB classification of ALL1 does not identify a specific subvariety of disease in categories Li and L2 even if it does (which it may well) in L3.
There is little doubt that FAB L2 ALL has a worse outlook when this type is evident at diagnosis,2-5 and there is also a correlation between the proportion of cells in the 'S' phase of the cell cycle 
tist. relapse off treatment. Lilleyman, Britton, and Laycock and FAB L2 morphology, 6 suggesting that this morphology may be related to the size of the growth fraction of a particular disease. It would appear from our findings that FAB L2 disease can also evolve as an expanding treatment-resistant sub-clone of an initially more differentiated and treatment-responsive tumour, and it is interesting that three out of four FAB Ll patients in our group who relapsed off treatment maintained this appearance but changed to FAB L2 when the disease subsequently re-emerged while they were on cytotoxic drugs. This would imply that acquired resistance to chemotherapy may be the stimulus to morphological metamorphosis. Despite the implicit heterogeneity of ALL, we feel that it is now clear that morphology cannot aid subclassification because, like the periodic acidSchiff reaction,7 it can change as the disease progresses. What FAB L2 appearances do apparently signify is the presence of a treatment-resistant form of the disease, either where this is found at diagnosis or when it appears for the first time after unsuccessful ablative therapy. 
